Press Release

2022-03-01

2022-03-01

BioEcho Receives Growth Equity Investment from Ampersand

BioEcho announced a minority investment from Ampersand Capital Partners, a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors.
2022-03-21

2022-03-21

The Nucleic Acid Experts – Certified Twice!

BioEcho achieves two important milestones for its quality management: DIN EN ISO 9001:2015 and DIN EN ISO 13485:2016.